Open Access
Subscription Access
Open Access
Subscription Access
Adrimycin:A Dramatic Break-Through in Cancer therapy
Subscribe/Renew Journal
No Abstract.
Subscription
Login to verify subscription
User
Font Size
Information
Abstract Views: 260
PDF Views: 0